6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01853306 [Disease Site] Ovarian Cancer, BRCA Mutated Breast Cancer [Description] 
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib in Subjects with Solid Tumors
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description